• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: September 19-23, 2011

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

September 19-23, 2011
FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs9/19/11- 9/20/11New York, NYN/AN/AUnited Nations Delegation Meeting
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs9/22/11Washington, DCMarsha Henderson N/ASpeech at the Society for Women’s Health Research Symposium on Clinical Trial Patient Recruitment and Retention
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs9/24/11– 9/25/11N/AN/AN/AFaster Cures Innovation Summit
John M. Taylor, III, J.D., Counselor to the Commissioner9/19/11- 9/23/11N/AN/AN/ANo Significant Meetings
Deborah M. Autor, Esq., Deputy Commissioner for Global Regulatory Operations and Policy9/19/11Washington, DCN/AN/ASpeech at PDA/FDA Joint Regulatory Conference
Dara A. Corrigan, Associate Commissioner for Regulatory Affairs9/19/11- 9/23/11 N/AN/AN/ANo Significant Meetings
Virginia Cox, Associate Commissioner for External Affairs9/19/11- 9/23/11N/AN/AN/ANo Significant Meetings
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products9/21/11Washington, DCSeveral FDA officials and staff membersMembers of the Institute of Medicine, PublicInstitute of Medicine Regulatory Workshop
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products9/22/11Rockville, MDSeveral FDA officials and staff membersMatthew L. Myers, Susan M. Liss, Anne J. Ford, Mark E. Greenwold, Daniel McGoldrick (Campaign for Tobacco Free Kids)Meet and Greet
Elizabeth H. Dickinson, Esq., Acting Chief Counsel9/22/11Silver Spring, MDSeveral FDA officials and staff membersTroy W. McCall, Roger N. Hayes, R. John Stubbs (Cetero Research); Marc Scheineson, Donald E. Segal (Alston & Bird representing Cetero)Drug Research
David Dorsey, J.D., Acting Associate Commissioner for Policy and Planning9/19/11- 9/23/11N/AN/AN/ANo Significant Meetings
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine9/21/11Washington, DCWilliam FlynnVeterinary Oversight of Antimicrobials Steering Committee MembersAmerican Veterinary Medical Association, Veterinary Oversight of Antimicrobials Steering Committee Meeting
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine9/22/11Washington, DCN/AN/AAnimal Health Institute Pet Night
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine9/21/11Washington, DCN/AConference AttendeesFDA/ Parenteral Drug Association Joint Regulatory Conference
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health9/19/11- 9/23/11N/AN/AN/ANo Significant Meetings
Michael M. Landa, Acting Director, Center for Food Safety and Applied Nutrition

9/19/11- 9/23/11

N/AN/AN/ANo Significant Meetings
Caroline Lewis, Associate Commissioner for Operations9/19/11- 9/23/11N/AN/AN/ANo Significant Meetings
Karen Midthun, M.D., Director, Center for Biologics Evaluation and Research9/19/11- 9/23/11N/AN/AN/ANo Significant Meetings
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health9/19/11- 9/23/11N/AN/AN/ANo Significant Meetings
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research9/19/11- 9/23/11N/AN/AN/ANo Significant Meetings
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods9/20/11Silver Spring, MDN/ABeth Johnson (Food Directions)Food Safety
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs9/21/11Silver Spring, MDMichael Ortwerth, Rosanne Hurwitz, Jayne Peterson, Cindy Abernethy, Vince TolinoAmy Comstock Rick (Parkinson's Action Network); Susan Winckler, Jim Ruvolo, Teresa Schofield (Council for American Medical Innovation); Paul Shieves (Biotechnology Industry Organization)FDA Advisory Committees
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research9/19/11- 9/23/11N/AN/AN/ANo Significant Meetings